MELVILLE, N.Y. –
June 19, 2018–Comtech Telecommunications Corp. (Nasdaq:CMTL) announced
today that during its fourth quarter of fiscal 2018, its New York-based
subsidiary, Comtech PST Corp., which is part of Comtech’s Government
Solutions segment, received a follow-on contract award for approximately
$3.6 million for solid-state, high-power RF amplifiers from a major
domestic medical instrumentation provider.
These amplifiers are used by one of the world’s largest suppliers of
image-guided radiotherapy (IGRT) and image-guided intensity modulated
radiation therapy (IMRT) medical equipment providing state-of-the-art
solutions for the treatment of cancer. These advanced forms of treatment
deliver versatile complex doses of radiation at greater speed and
accuracy thereby minimizing damage to surrounding healthy tissue.
In commenting on this contract award, Fred Kornberg, President and Chief
Executive Officer of Comtech Telecommunications Corp., said, “This
significant award demonstrates Comtech’s technical strength in
delivering solid-state, high-power RF amplifiers for medical systems. We
believe the medical market for our amplifiers remains strong and we look
forward to continuing to develop innovative products to address this
important market.”
Comtech PST Corp. (www.comtechpst.com)
is a leading independent supplier of broadband, high-power, high
performance RF microwave amplifiers and control components for use in a
broad spectrum of applications including defense, radar, medical,
satellite communications systems and instrumentation.
Comtech Telecommunications Corp. progetta, sviluppa, produce e commercializza
prodotti, sistemi e servizi innovativi per soluzioni di comunicazione
soluzioni di comunicazione avanzate. L'azienda vende i suoi prodotti a una base di clienti diversificata nei mercati delle comunicazioni
mercati globali delle comunicazioni commerciali e governative.
Alcune informazioni contenute in questo comunicato stampa contengono dichiarazioni che sono
che sono di natura previsionale e comportano alcuni rischi e incertezze significativi.
incertezze. I risultati effettivi potrebbero differire materialmente da tali
informazioni previsionali. I documenti della Commissione per i Titoli e gli Scambi della Società
Commissione della Società identificano molti di questi rischi e incertezze. Qualsiasi
informazioni previsionali contenute nel presente comunicato stampa sono qualificate nella loro
interamente dai rischi e dalle incertezze descritti in tali documenti della Commissione per i Titoli e gli Scambi.
Commissione di Borsa.
PCMTL
View source version on businesswire.com: https://www.businesswire.com/news/home/20180619005093/en/
Media:
Michael D. Porcellana, Vicepresidente senior e Direttore finanziario
Finanziario
631-962-7000
[email protected]
